Abstract: The invention relates to an antimicrobial mixture containing 4-(3-ethoxy-4-hydroxy-phenyl)butan-2-one and a diol compound chosen from 1,3-propanediol, 1,2-octane-diol and 1,2-decanediol, and also to a cosmetic composition containing such a mixture. Use in caring for, making up and cleansing keratin materials.
Abstract: The invention provides compounds that inhibit FTO (fat mass and obesity), including pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof, particularly obesity, with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
Type:
Grant
Filed:
January 12, 2020
Date of Patent:
April 27, 2021
Assignee:
National Institute of Biological Sciences, Beijing
Abstract: The invention provides compounds that inhibit FTO (fat mass and obesity), including pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof, particularly obesity, with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
Type:
Grant
Filed:
December 22, 2017
Date of Patent:
January 14, 2020
Assignee:
National Institute of Biological Sciences, Beijing
Abstract: Methods for the prevention and treatment of ocular disorders, in particular glaucoma, through blocking the toxic effects of ?-amyloid (A?) derivatives, and pharmaceutical compositions for effecting such prevention and treatment thereof.
Abstract: The present invention in one embodiment provides a compound of Formula I:(I), or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.
Abstract: The invention provides a compound of formula I: or a salt thereof, wherein R1-R3 have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as antibacterial agents.
Type:
Grant
Filed:
January 7, 2013
Date of Patent:
December 13, 2016
Assignee:
Rutgers, The State University of New Jersey
Abstract: Bicyclic sesquiterpene compounds exhibiting antifungal characteristics are formulated into antifungal compositions for use in the treatment of fungal infections in humans, animals, and plants. Particularly, sesquiterpene alcohols derived from drimane have been discovered to possess broad-spectrum antifungal characteristics. Exemplary antifungal sesquiterpene compounds include albicanol and drimenol, which have been shown effective against a number of pathogenic fungi.
Type:
Grant
Filed:
January 21, 2014
Date of Patent:
March 17, 2015
Assignee:
Kansas State University Research Foundation
Abstract: The present invention relates to formulations having an irritation-reducing action, corresponding cosmetic and pharmaceutical products as well as associated methods and uses thereof.
Type:
Grant
Filed:
October 14, 2009
Date of Patent:
February 10, 2015
Assignee:
Symrise AG
Inventors:
Martina Herrmann, Oskar Koch, Imke Meyer
Abstract: A composition includes a liquid. The liquid aerosolizes for delivery to a user by an airway. The liquid includes an agent that activates a TRPV3 channel. The agent includes a terpenoid compound.
Type:
Application
Filed:
August 1, 2014
Publication date:
February 5, 2015
Applicant:
SENTIENS, LLC
Inventors:
Inna S. Timokhina, Reid von Borstel, Dennis Tan, John Siverling
Abstract: Provided is a pesticidal Flavobacterium strain and bioactive compositions and metabolites derived therefrom as well as their methods of use for controlling pests.
Abstract: The present disclosure describes economical processes to improve the bioavailability of nutraceuticals by formulations that induce micronization and sustained release. The inventive process can be used to increase the solubility and bioavailability of lipophilic and moderately water-soluble nutraceuticals by combining excipients that increase the solubility and induce sustained release of the active compounds. The inventive process also can be used to increase the residence time of highly water-soluble nutraceuticals that are metabolized and eliminated quickly from the body, consequently increasing the therapeutic potential. The disclosed formulations advantageously are freely flowing powders that can be used to formulate with other ingredients into tablets, capsules, or the like; or used as bulk powders.
Abstract: The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm3.
Abstract: The present invention relates to a novel composition comprising danielone and derivatives thereof as well as to the use of such compositions in skin lightening. More particularly, the present invention relates to danielone and derivatives thereof for use in topical compositions for smoothening skin color irregularities, for reducing melanin formation in the human skin, for lightening/brightening human skin and/or for treatment of pigmentation disorders which comprises topically administering an effective amount of danielone and derivatives thereof to the appropriate skin area of a person in need of such beautifying agent, or treatment.
Type:
Application
Filed:
December 28, 2012
Publication date:
January 1, 2015
Inventors:
Remo Campache, Piero Geotti-Bianchini, Hugo Ziegler
Abstract: The present invention provides masking compositions that include a lower alkyl carboxylic acid, e.g. acetic acid. Also provided is a masking composition that includes (a) a lower alkyl carboxylic acid (e.g. acetic acid), a warming sensate (e.g. vanillin or vanillyl butyl ether) and/or a cooling sensate (e.g. menthol or isopulegol).
Type:
Grant
Filed:
December 11, 2009
Date of Patent:
December 30, 2014
Assignee:
Takasago International Corporation
Inventors:
David J. Spence, Charles Manley, Carter B. Green
Abstract: Provided herein are bitter taste receptor ligands, related agents, combinations, compositions, methods and systems for modulating release of a metabolic hormone in vitro or in vivo from cells of the GI tract of an individual.
Type:
Application
Filed:
June 30, 2014
Publication date:
December 11, 2014
Inventors:
William A. GODDARD, III, Mark MENNA, Stephan PANDOL, Ravinder ABROL
Abstract: According to the invention there is provided a compound of formula (I): wherein R1, R2, R3 and n have meanings given in the description, or a pharmaceutically acceptable solvate, salt or prodrug thereof for use in the treatment of osteoporosis and/or osteopenia.
Abstract: A skin augmentation composition comprises a therapeutically effective amount of a combination of a gingerol and a curcumin and a cosmetically or pharmaceutically acceptable carrier. Methods for enhancing the repair of damaged skin and the prevention of developing wounds in a subject having damaged skin comprises administering to a portion of damaged skin, a composition comprising a therapeutically effective amount of a combination of a gingerol and a curcumin and a cosmetically or pharmaceutically acceptable carrier.
Abstract: The present invention refers to new derivatives of the penta-1,4-dien-3-ones, as well as their processes of preparation. These compounds present strong antitumoral activity and promising antiparasitic action, behaving as almost atoxic by laboratory assays and also by hystopathologic studies. The present invention refers also to a pharmaceutical composition including the referred compounds, method of treatment for cancer and parasitic diseases.
Type:
Grant
Filed:
July 6, 2007
Date of Patent:
October 14, 2014
Assignee:
Universidade Bandeirante de Sao Paulo-Academia, Paulista Anchieta S/C Ltda
Inventors:
José Agustin Quincoces Suárez, Durvanei Augusto Maria, Daniela Goncales Rando, Clizete Aparecida Sbravate Martins, Paulo Celso Pardi, Pamela Oliveira De Souza
Abstract: For enhancing bioavailability, a composition is administered comprising a Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) agonist with a combined Scoville Heat Unit (SHU) milligram (mg) dose in the range of 280,000 to 400,000 SHU mg.
Abstract: This invention relates to compounds of Formula (I), (II), or (III) as shown in the specification, which contain a 1,5-diphenylpenta-1,4-dien-3-one backbone. These compounds can be used to treat cancer, inflammatory disease, or autoimmune disease.
Type:
Grant
Filed:
August 16, 2011
Date of Patent:
September 2, 2014
Assignee:
AndroScience Corporation
Inventors:
Charles C-Y Shih, Toshio Kitamura, Qian Shi, Toshiyuki Kawashima, Hui-Kang Wang
Abstract: The present invention relates to the anti-convulsant activity of turmeric oil and its volatile bisabolene sesquiterpenoids ar-turmerone, ?-turmerone, ?-turmerone (curlone) and ?-atlantone, as an anticonvulsant agent for the treatment of epilepsy and/or as therapeutic agents for the treatment of disorders of the central nervous system, including tremor, pain, mood disorders (including depression, bipolar disorder, attention deficit-hyperactivity disorder, and schizophrenia), and neurodegenerative diseases.
Type:
Application
Filed:
July 4, 2012
Publication date:
August 28, 2014
Applicant:
KATHOLIEKE UNIVERSITEIT LEUVEN
Inventors:
Peter De Witte, Camila V. Esguerra, Alexander D. Crawford, Adriana Monserrath Orellana Paucar
Abstract: A method for improving tetracycline-resistance of A. baumannii, by providing a ginger compound combined with tetracycline to against A. baumannii infection, wherein the ginger compound comprises [6]-dehydrogingerdione, [6]-shogaol and [6]-gingerol or [10]-gingerol, [6]-shogaol and [6]-gingerol.
Abstract: The present invention relates to a cosmetic method for treating and/or preventing greasy skin or greasiness-prone skin and/or the associated cutaneous aesthetic defects, comprising the topical application to the skin of a composition comprising, in a cosmetically acceptable medium, at least one compound of formula (I): in which: R represents a hydrogen atom or a saturated or unsaturated and linear or branched C1-C6 hydrocarbon radical; R? represents a saturated or unsaturated and linear or branched C1-C18 hydrocarbon radical, optionally substituted by a hydroxyl group; C—X represents C?O or CH—OH.
Abstract: Disclosed are methods of cultivating or isolating a microorganism using one or more quinones as growth factors. Also disclosed are methods of treating a mammalian species with deficiency in symbionts using such compounds.
Type:
Application
Filed:
May 24, 2012
Publication date:
July 17, 2014
Applicant:
NORTHEASTERN UNIVERSITY
Inventors:
Kim Lewis, Pallavi Murugkar, Anthony D'onofrio, Eric Stewart, Eric Dimise, Jon Clardy, Kathrin Witt, Bijaya Sharma
Abstract: A method for promoting proliferation and/or migration of skin cells includes providing a composition containing a compound of formula (I) below; and administrating to the skin cells the composition.
Abstract: A pharmaceutical composition for nasal administration comprising: a nanoemulsified curcumin component; a liquid medium for the curcumin component; and a pharmaceutically acceptable excipient. The curcumin component is a natural curcuminoid, a synthetic curcuminoid, a metabolite of a natural or synthetic curcuminoid, or a mixture thereof. The excipient is effective in increasing the bioavailability of the curcumin component.
Abstract: The present invention provides a computer-assisted method of generating a protonophore requiring the use of a computer including a processor. The method includes: designing the protonophore, calculating, using the processor, an estimated protonophoric activity; producing the protonophore if the estimated protonophoric activity corresponds to an U50 of about 20 ?M or less; and determining the uncoupling activity of the protonophore. The present invention also provides novel protonophores that meet the above requirement and their methods of use.
Abstract: The invention encompasses micelle assemblies, compositions having micelle assemblies, and methods for preparing micelle assemblies and compositions thereof. The invention also encompasses a prolamine protein conjugated to a polymer, such as a polyethylene glycol (PEG) chain, which conjugates can be used to prepare micelle assemblies. The invention further encompasses methods of encapsulating molecules using the conjugates of the invention. The micelle assemblies can be used for a variety of applications, such as treating cancer, targeting tumors, reducing the toxicity of a drug in vivo, increasing the efficacy of an encapsulated agent in vivo, protecting an encapsulated agent against degradation, and enhancing the water solubility of a drug or other agent.
Type:
Grant
Filed:
February 24, 2012
Date of Patent:
April 15, 2014
Assignee:
South Dakota State University
Inventors:
Omathanu P. Perumal, Satheesh K. Podaralla, Ranjith Kumar Averineni
Abstract: A buccally administered dosage for assisting with the relief of common digestive complaints where the dosage formed into a hard candy dosage drop, where the dosage is a sugar base infused with a botanical derivative that has concentrated active compositions in sufficient concentration to provide a soothing effect of digestive upset, and where the drop has favorable organoleptic properties.
Abstract: The invention relates to a composition comprising, in a physiologically acceptable aqueous medium, 4-(3-ethoxy-4-hydroxyphenyl)-2-butanone and a solvent with solubility parameters in the Hansen solubility space such that 4.5<?, <30 and 15<?d<22. Use for caring for, making up and cleansing keratin materials.
Abstract: The present invention relates to the use, as an antidandruff agent, of a compound of formula: in which: R1 represents a hydrogen atom or a hydrocarbon-based radical; R? represents a C1-C18 hydrocarbon-based radical, optionally substituted with a hydroxyl group; C—X represents C?O or CH—OH.
Abstract: Use of gingerone or derivatives thereof for reducing or delaying the signs of skin ageing. The present invention relates to the cosmetic use of at least one compound of general formula (I): in which:—R1 represents a methyl or ethyl radical;—R2 represents a hydrogen atom or a methyl or ethyl radical;—R3 represents a linear C1-C6 or branched C3-C6 alkyl radical, or a linear C2-C6 or branched C3-C6 alkenyl radical; and—X represents =O or —OH, as an agent for reducing and/or delaying the signs of skin ageing.
Abstract: A composition-of-matter comprising a substance usable in producing packaging material and at least one compound selected from the group consisting of ar-turmerone, a sesquiterpene alcohol and a turmeric oleoresin solid residue.
Type:
Application
Filed:
September 30, 2013
Publication date:
January 30, 2014
Applicants:
Biopack Ltd., The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organizat
Abstract: This invention relates to the use of pterosin compounds of formula I for treating diabetes including type I and type II. Also disclosed is the use of the pterosin compounds for treating obesity.
Type:
Grant
Filed:
January 26, 2010
Date of Patent:
January 21, 2014
Assignees:
Taipei Medical University, National Taiwan University, National Tsing Hua University, DCB-USA LLC
Inventors:
Feng-Lin Hsu, Shing-Hwa Liu, Biing-Jiun Uang
Abstract: A description is given of (4-haloalkyl-3-thiobenzoyl)cyclohexanediones of the formula (I) and of their use as herbicides. In this formula (I), X, Y, R1, R2, R3, and R4 are radicals such as hydrogen and organic radicals such as alkyl. A and Z are oxygen or alkylene.
Type:
Grant
Filed:
July 20, 2011
Date of Patent:
December 10, 2013
Assignee:
Bayer Cropscience AG
Inventors:
Hartmut Ahrens, Dieter Feucht, Elmar Gatzweiler, Isolde Haeuser-Hahn, Christopher Hugh Rosinger
Abstract: Novel compounds below are useful for preventing or treating diseases caused by protozoans. At least one of a compound represented by Formula (I) (wherein, X represents a hydrogen atom or a halogen atom; R1 represents a hydrogen atom; R2 represents a hydrogen atom or a C1-7 alkyl group; R3 represents —CHO, —C(?O)R5, —COOR5 (wherein R5 represents a C1-7 alkyl group), —CH2OH or —COOH; and R4 represents a C1-16 alkyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), a C2-16 alkenyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), or a C2-16 alkynyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s)), an optical isomer thereof, and a pharmaceutically acceptable salt is used.
Abstract: The invention concerns compounds DLBS1425E2.2 and DLBS1425F1 isolated and identified from the extract of the plant Phaleria macrocarpa (Scheff.) Boerl. The invention also relates to the use of said compounds, either as a single active compound or in combination, in a pharmaceutical dosage form that has anti-proliferative activity of cancer cells, and its use relating to female related diseases. Formula (I).
Type:
Grant
Filed:
November 26, 2009
Date of Patent:
October 29, 2013
Assignee:
PT. Dexa Medica
Inventors:
Asep Aripin, Poppy Firzani Arifin, Raymond R. Tjandrawinata
Abstract: A method of treating airway remolding symptom caused by phthalate esters, by providing a medication comprising: a ginger compound selected from one of (a) [6]-shogaol, (b) [6]-shogaol and [10]-gingerol, (c) [6]-shogaol and [8]-gingerol, and (d) [6]-shogaol and [6]-gingerol, and an acceptable carrier or excipient, which can relieve, the airway remodeling symptoms of asthma, particularly to phthalate ester-induced airway remodeling, by suppressing the proliferation and migration of bronchial smooth muscle cells and reducing the instances of fatal asthma.
Abstract: A bacterial autoinducer, CAI-1, was purified and its structure identified. Methods for synthesis of the autoinducer and its analogues were elucidated. Methods of using the autoinducer or its analogues for treating bacterial pathogenicity and bio film formation are described. Methods for prevention and treatment of cholera are described. Synthetic (S)-3-hydroxytridecan-4-one functions as well as natural CAI-1 in repressing production of the virulence factor toxin co-regulated pilus (TCP). Strategies are described to manipulate bacterial quorum sensing in the clinical arena.
Type:
Grant
Filed:
October 1, 2008
Date of Patent:
September 17, 2013
Assignee:
The Trustees of Princeton University
Inventors:
Bonnie Bassler, Martin Semmelhack, Douglas A. Higgins, Megan Eileen Bolitho, Kristina M. Kraml, Wai-Leung Ng
Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
Type:
Grant
Filed:
January 12, 2011
Date of Patent:
July 23, 2013
Assignee:
Emisphere Technologies, Inc.
Inventors:
Mohammed Amin Khan, Bryan Edward Jones, John McNeill McGill
Abstract: The present invention provides organic nanoparticles that include a molecule having a Log P value of about 3 or above, an amphiphilic diblock copolymer or a surfactant, and a pharmaceutically-acceptable hydrophilic polymer. The present invention also provides methods of making these nanoparticles, e.g., by flash nanoprecipitation, with control over particle size and surface properties. The methods of the present invention provide a means for co-precipitating a water-insoluble compound with an amphiphilic stabilizer within a few milliseconds. The nanoparticles of the present invention exhibit high drug loading, e.g., 50% w/w, and can be produced with a mean particle size less than 200 nm and with a narrow particle size distribution.
Abstract: The invention relates to pharmaceutical compositions containing combinations of formoterol and ciclesonide and the use of such pharmaceutical compositions in medicine, in particular, the prophylaxis and treatment of respiratory disease.
Abstract: A compound has Formula VIII where, X is —C(O)R, —C(O)OR, —CN, —NO2, —S(O)2R?, —P(O)(OR)2; each R is individually H, alkyl, or alkenyl; R? is alkyl or akenyl; R1 is aryl, alkenyl, arylalkenyl, heterocyclyl, or heteroaryl; and R2, R3, R4, R5, R6, R7, R8, R9, R10, and R11 are individually H, alkoxy, or hydroxy. In some cases, X is NO2. Pharmaceutical compositions of the compound of Formula VIII with a pharmaceutically acceptable carrier may be prepared. The compounds may be used for inhibition of cyclooxygenase-2.
Type:
Grant
Filed:
March 4, 2010
Date of Patent:
April 2, 2013
Assignee:
Indian Institute of Technology Bombay
Inventors:
Irishi N. N. Namboothiri, Narasimham Ayyagari, Deena Jose
Abstract: An oral formulation includes a plurality of agents that promote cellular detoxification. Agents can be included that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject, wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants, and at least one gene encoding cellular detoxifiers. In addition, at least one of the plurality of agents attenuates inflammation.
Type:
Application
Filed:
March 14, 2012
Publication date:
March 21, 2013
Applicant:
NSE Products, Inc.
Inventors:
Angela Mastaloudis, Steve Wood, Jamie Louis Barger, Richard Weindruch, Tomas Alberto Prolla, Mark Bartlett, Scott B. Ferguson
Abstract: The present invention relates to compounds of formula I or II:—wherein R is an alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group, that may be substituted or unsubstituted, and that optionally includes at least one heteroatom in its carbon skeleton; R1 is hydrogen, or an alkyl, substituted alkyl, alkenyl, alkynyl, aryl, substituted aryl, or aralkyl group; and R2 is an alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group containing 4-12 carbon atoms, that may be substituted or unsubstituted, and that optionally includes at least one heteroatom in its carbon skeleton; provided that in a compound of formula I, when R1 is an iso-propyl or phenyl group, R2 is not an acetyl or tert-butyldimethylsilyl group; and their use in therapeutic, diagnostic and research methods.
Type:
Grant
Filed:
July 26, 2007
Date of Patent:
February 5, 2013
Assignee:
Crawford Healthcare Holdings Limited
Inventors:
Stanley M. Roberts, Gabriella M. Santoro
Abstract: The invention provides novel compounds and formulations of turmeric oil, fish oil, aspirin and anti-cancer drugs (paclitaxel) having anti-inflammatory, analgesic and/or anti-cancer activity.
Abstract: A medication for therapy or prophylaxis of asthma, comprises a ginger compound selected from a group of [6]-gingerol, [10]-gingerol, [6]-shogaol and [6]-gingerol; and an acceptable carrier or excipient, which can relieve the airway remodeling symptoms of asthma, particularly to phthalate induced airway remodeling, by suppressing the proliferation and migration of bronchial smooth muscle cells and reducing the instances of fatal asthma.
Abstract: Compositions and methods for managing or treating chronic pain are provided. More particularly, methods are provided for managing or treating chronic pain by administering to a patient in need thereof an effective amount of propofol or a propofol derivative having limited anesthetic properties. Methods of modulating HCN channel gating are also provided. Pharmaceutically acceptable compositions for, e.g., modulating HCN channel gating are further provided.
Type:
Application
Filed:
August 10, 2010
Publication date:
January 3, 2013
Inventors:
Gareth R. Tibbs, Pamela Flood, Peter Goldstein
Abstract: An antiwrinkle agent, lipolysis promoter, external composition for skin, and food and beverage composition having for an active ingredient thereof a compound represented by general formula (1): (wherein R represents a hydrogen atom or an acyl group having 2 to 20 carbon atoms). or an extract obtained from guinea ginger and/or an acylation treatment product of said extract.
Type:
Application
Filed:
August 27, 2012
Publication date:
December 20, 2012
Inventors:
Jun Sugita, Takeshi Ikemoto, Yumiko Akazawa, Yurie Kobayashi, Mitsumasa Mitani, Akinori Haratake, Aya Komiya
Abstract: The present invention is based on the discovery that the administration of at least one immunoconjugate and at least one chemotherapeutic agent provides an unexpectedly superior treatment for cancer. The present invention is directed to compositions comprising at least one immunoconjugate and at least one chemotherapeutic agent and to methods of treating cancer using at least one immunoconjugate and at least one chemotherapeutic agent. The present invention also provides methods of modulating the growth of selected cell populations, such as cancer cells, by administering a therapeutically effective amount of at least one chemotherapeutic agent and at least one immunoconjugate.